COSMOPOL INT'L (00120) released its interim results, reporting a net loss of HKD 232.4 million, an increase of 311.3% year-on-year.
COSMOPOL INT'L (00120) released its interim results for 2026, reporting revenue of HKD 158.8 million, a year-on-year increase of 892.5%; the loss attributable to equity holders of the parent company was HKD 232.4 million, an increase of 311.3% year-on-year; basic loss per share was HKD 0.1243.
COSMOPOL INT'L (00120) released its interim results for 2026, reporting revenue of HK$158.8 million, a year-on-year increase of 892.5%; the loss attributable to equity holders of the parent company was HK$232.4 million, a year-on-year increase of 311.3%; basic loss per share was HK$0.1243.
The increase in losses during the reviewed half-year period was mainly attributed to the impact of recent changes on the afforestation project located in Urumqi, which has been approved for land development, leading to the need for impairment of the prepayments related to the afforestation project that had already been included in the cost accounts.
Related Articles

US Stock Market Move | Kanzhun Ltd. Sponsored ADR (BZ.US) surged over 18% with Q2 revenue increasing by 14.1% year-on-year.

US Stock Market Move | The MSCI index exclusion risk strikes again, and Strategy (MSTR.US) has dropped over 4%.

MP CARDIOFLOW-B(02160) has appointed Zhang Ruinian as the company's president.
US Stock Market Move | Kanzhun Ltd. Sponsored ADR (BZ.US) surged over 18% with Q2 revenue increasing by 14.1% year-on-year.

US Stock Market Move | The MSCI index exclusion risk strikes again, and Strategy (MSTR.US) has dropped over 4%.

MP CARDIOFLOW-B(02160) has appointed Zhang Ruinian as the company's president.

RECOMMEND





